Form 10 Explorer
10-Q
Quarterly Report
ACRO BIOMEDICAL CO., LTD.

CIK: 1622996

File #: 000-55643

Period End: Sep 30, 2023

Fiscal Year: 2023

View on EDGAR
Balance Sheet
33 line items · 2 periods
XBRL
ItemSep 30, 2023Dec 31, 2022
Balance Sheets
Current Assets
Cash
3,2715,852
Accounts Receivable
0638,500
ASSETS
Purchase deposit for inventory
012,000
Other Non-Operating Current Assets
5,0001,185
Other Current Assets
4,2300
Total Current Assets
12,501657,537
Operating Lease Right-of-Use Asset
6,52625,719
Security deposit
04,230
TOTAL ASSETS
19,027687,486
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current Liabilities
Accounts Payable
153,03676,571
Other Current Liabilities
20,00020,000
Other Non-Operating Current Liabilities
79,07878,826
Operating Lease Liability, Current
6,52625,719
Total Current Liabilities
258,640201,116
TOTAL LIABILITIES
258,640201,116
Stockholders' Equity (Deficit)
Preferred Stock
00
Total Stockholders' Equity
60,04260,042
Total Stockholders' Equity
32,297,60332,295,236
Deferred stock compensation
08,060,983
Total Stockholders' Equity
(32,597,258)(23,807,925)
Total Stockholders' Equity (Deficit)
(239,613)486,370
Accumulated Deficit
(32,597,258)(23,807,925)
Deferred stock compensation
0(8,060,983)
Additional Paid-In Capital
32,297,60332,295,236
Common Stock
60,04260,042
Preferred Stock
00
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
19,027687,486